2018 Form 10-K Financial Statement

#000164033418001936 Filed on October 15, 2018

View on sec.gov

Income Statement

Concept 2018 2017 Q2 2017
Revenue $4.249K $0.00 $995.00
YoY Change 327.04% -83.64%
Cost Of Revenue $1.349K
YoY Change
Gross Profit $2.900K
YoY Change
Gross Profit Margin 68.25%
Selling, General & Admin $600.0K $220.0K $500.0K
YoY Change 20.0% 120.0% 648.86%
% of Gross Profit 20689.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $31.74K $10.00K $43.60K
YoY Change -27.19% 0.0% -35.23%
% of Gross Profit 1094.62%
Operating Expenses $636.4K $230.0K $546.8K
YoY Change 16.38% 109.09% -72.97%
Operating Profit -$632.1K -$545.8K
YoY Change 15.82% -72.94%
Interest Expense -$424.6K -$140.0K $46.05K
YoY Change -1021.94% -65.0% -84.23%
% of Operating Profit
Other Income/Expense, Net -$1.362M -$154.5K
YoY Change 781.49% -83.3%
Pretax Income -$1.990M -$370.0K -$700.0K
YoY Change 184.29% -27.45% -76.19%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.994M -$370.0K -$700.3K
YoY Change 184.76% -27.45% -76.2%
Net Earnings / Revenue -46934.71% -70384.22%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.40 -$0.15 -$0.30
COMMON SHARES
Basic Shares Outstanding 464.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 2017 Q2 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.00K $40.00K $40.00K
YoY Change 25.0% 300.0% 300.0%
Cash & Equivalents $50.00K $42.57K $40.00K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.00K $42.57K $40.00K
YoY Change 25.0% 126.37% 100.0%
LONG-TERM ASSETS
Property, Plant & Equipment $10.00K $39.04K $40.00K
YoY Change -75.0% -52.76% -50.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $39.04K $40.00K
YoY Change -100.0% -52.76% -50.0%
TOTAL ASSETS
Total Short-Term Assets $50.00K $42.57K $40.00K
Total Long-Term Assets $0.00 $39.04K $40.00K
Total Assets $50.00K $81.61K $80.00K
YoY Change -37.5% -19.55% -20.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $280.0K $5.993K $10.00K
YoY Change 2700.0% 29.08%
Accrued Expenses $220.0K $0.00 $130.0K
YoY Change 69.23% -100.0% 333.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K $170.0K $170.0K
YoY Change 76.47%
Total Short-Term Liabilities $1.900M $496.8K $500.0K
YoY Change 280.0% 1188.8% 1150.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.900M $496.8K $500.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.900M $496.8K $500.0K
YoY Change 280.0% 1188.8% 1150.0%
SHAREHOLDERS EQUITY
Retained Earnings -$4.783M
YoY Change 17.15%
Common Stock $52.00K
YoY Change 11.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.850M -$415.2K -$420.0K
YoY Change
Total Liabilities & Shareholders Equity $50.00K $81.61K $80.00K
YoY Change -37.5% -19.55% -20.0%

Cashflow Statement

Concept 2018 2017 Q2 2017
OPERATING ACTIVITIES
Net Income -$1.994M -$370.0K -$700.3K
YoY Change 184.76% -27.45% -76.2%
Depreciation, Depletion And Amortization $31.74K $10.00K $43.60K
YoY Change -27.19% 0.0% -35.23%
Cash From Operating Activities -$135.6K -$80.00K -$270.7K
YoY Change -49.92% 700.0% 238.35%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$30.00K $0.00 $0.00
YoY Change
Cash From Investing Activities -$25.00K $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $200.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $165.2K 100.0K $298.6K
YoY Change -44.68% 400.0% 171.46%
NET CHANGE
Cash From Operating Activities -$135.6K -80.00K -$270.7K
Cash From Investing Activities -$25.00K 0.000 0.000
Cash From Financing Activities $165.2K 100.0K $298.6K
Net Change In Cash $4.629K 20.00K $27.93K
YoY Change -83.43% 100.0% -244.72%
FREE CASH FLOW
Cash From Operating Activities -$135.6K -$80.00K -$270.7K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$80.00K -$270.7K
YoY Change 700.0% 170.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Registrant Name
EntityRegistrantName
APPYEA, INC
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0001568969
CY2018 dei Trading Symbol
TradingSymbol
apyp
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2018 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1240477060 shares
CY2017Q4 dei Entity Public Float
EntityPublicFloat
584842 usd
CY2018 dei Document Type
DocumentType
10-K
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14637 usd
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42567 usd
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47196 usd
CY2017Q2 us-gaap Assets Current
AssetsCurrent
42567 usd
CY2018Q2 us-gaap Assets Current
AssetsCurrent
47196 usd
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39044 usd
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7300 usd
CY2017Q2 us-gaap Assets
Assets
81611 usd
CY2018Q2 us-gaap Assets
Assets
54496 usd
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5993 usd
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
275312 usd
CY2017Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
128000 usd
CY2018Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
224000 usd
CY2017Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
174904 usd
CY2018Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
290823 usd
CY2018Q2 apyp Convertible Debt Related Party
ConvertibleDebtRelatedParty
8977 usd
CY2017Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
73608 usd
CY2018Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
88087 usd
CY2016Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1452 usd
CY2017Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
114316 usd
CY2018Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1016865 usd
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
496821 usd
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1904064 usd
CY2017Q2 us-gaap Liabilities
Liabilities
496821 usd
CY2018Q2 us-gaap Liabilities
Liabilities
1904064 usd
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
51997 usd
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
124047 usd
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4210156 usd
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4740277 usd
CY2017Q2 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
105000 usd
CY2018Q2 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
62727 usd
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4782863 usd
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6777119 usd
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
62899 usd
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-415210 usd
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-1849568 usd
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81611 usd
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54496 usd
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
218826 usd
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
250570 usd
CY2017Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
87240 usd
CY2018Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
81968 usd
CY2017Q2 apyp Debt Instrument Unamortized Discount Related Party Current
DebtInstrumentUnamortizedDiscountRelatedPartyCurrent
0 usd
CY2018Q2 apyp Debt Instrument Unamortized Discount Related Party Current
DebtInstrumentUnamortizedDiscountRelatedPartyCurrent
0 usd
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
60000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
519973313 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1240477060 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
519973313 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1240477060 shares
CY2018 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2900 usd
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
995 usd
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4249 usd
CY2017 us-gaap Professional Fees
ProfessionalFees
365103 usd
CY2018 us-gaap Professional Fees
ProfessionalFees
418044 usd
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
138087 usd
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
186574 usd
CY2017 us-gaap Depreciation
Depreciation
43600 usd
CY2018 us-gaap Depreciation
Depreciation
31744 usd
CY2017 us-gaap Operating Expenses
OperatingExpenses
546790 usd
CY2018 us-gaap Operating Expenses
OperatingExpenses
636362 usd
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-545795 usd
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-632113 usd
CY2017 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-108478 usd
CY2018 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-912590 usd
CY2017 us-gaap Interest Expense
InterestExpense
46050 usd
CY2018 us-gaap Interest Expense
InterestExpense
424553 usd
CY2018 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
-476 usd
CY2018 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
24524 usd
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-154528 usd
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1362143 usd
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-700323 usd
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-1994256 usd
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
470400985 shares
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
988229338 shares
CY2018 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
32000 usd
CY2018 apyp Common Stock Issued For Settlement Agreement
CommonStockIssuedForSettlementAgreement
67500 usd
CY2017 apyp Common Stock Payable For Services
CommonStockPayableForServices
-105000 usd
CY2017 apyp Issuance Of Convertible Notes For Services
IssuanceOfConvertibleNotesForServices
25000 usd
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
27760 usd
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
329219 usd
CY2018 apyp Penalty On Convertible Note
PenaltyOnConvertibleNote
15000 usd
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4167 usd
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1350 usd
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
269319 usd
CY2017 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
96000 usd
CY2018 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
96000 usd
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18290 usd
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
80334 usd
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-270678 usd
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-135550 usd
CY2018 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
25000 usd
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000 usd
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200 usd
CY2017 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
225000 usd
CY2018 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
142167 usd
CY2018 apyp Proceeds From Convertible Notes Payable Related Party Net Of Original Issue Discounts
ProceedsFromConvertibleNotesPayableRelatedPartyNetOfOriginalIssueDiscounts
8333 usd
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
98517 usd
CY2018 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
21098 usd
CY2017 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
24909 usd
CY2018 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
6619 usd
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
298608 usd
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
165179 usd
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27930 usd
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4629 usd
CY2017 us-gaap Interest Paid
InterestPaid
0 usd
CY2018 us-gaap Interest Paid
InterestPaid
0 usd
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2017 apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
31600 usd
CY2018 apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
164657 usd
CY2017 us-gaap Notes Reduction
NotesReduction
85614 usd
CY2018 us-gaap Notes Reduction
NotesReduction
295541 usd
CY2017 apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
90000 usd
CY2018 apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
285500 usd
CY2018 us-gaap Nature Of Operations
NatureOfOperations
<p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>1. NATURE OF OPERATIONS</b></p><p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p><p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">AppYea, Inc. ("AppYea", "the Company", "we" or "us") was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history.</p><p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p><p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company incorporated a wholly-owned subsidiary, &#8220;AppYea Holdings, Inc.&#8221; in state of South Dakota on January 13, 2017 and "The Diagnostic Centers Inc." in State of South Dakota on August 2, 2017.</p><p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p><p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Through its wholly owned subsidiary, The Diagnostic Centers, Inc., AppYea markets comprehensive diagnostic testing services to physician offices, clinics, hospitals, long term care facilities, healthcare groups, and other healthcare providers.</p><p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p><p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company's common stock is traded on the OTC Markets (www.otcmarkets.com) under the symbol "APYP". The first day of trading on the OTC Markets was December 15, 2014.</p>
CY2017Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
37000 usd
CY2018Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
78947 usd
CY2018Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
19000 usd
CY2018Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.05 pure
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div><p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Use of Estimates and Assumptions</i></p><p align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p><div align="justify" style="margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires that management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</div></div>
CY2018Q2 apyp Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
0.0004
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
27760 usd
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
320886 usd
CY2017 apyp Class Of Warrant Or Right Weighted Average Exercise Price Forfeited Or Canceled
ClassOfWarrantOrRightWeightedAverageExercisePriceForfeitedOrCanceled
0.00
CY2018 apyp Class Of Warrant Or Right Weighted Average Exercise Price Forfeited Or Canceled
ClassOfWarrantOrRightWeightedAverageExercisePriceForfeitedOrCanceled
0.00
CY2018 apyp Warrants Outstanding Weighted Average Remaining Contractual Life
WarrantsOutstandingWeightedAverageRemainingContractualLife
P3Y4M24D
CY2018 apyp Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
592916818 shares
CY2018Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2018Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.0499 pure
CY2018Q2 apyp Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
1856868 usd
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2017Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
250877 usd
CY2018Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
345614 usd
CY2017Q2 us-gaap Interest Payable Current
InterestPayableCurrent
11267 usd
CY2018Q2 us-gaap Interest Payable Current
InterestPayableCurrent
27177 usd
CY2017Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
174904 usd
CY2018Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
290823 usd
CY2017Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
174904 usd
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
290823 usd
CY2017Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2018Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2016Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5000000 shares
CY2018Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
592916818 shares
CY2017 apyp Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
5000000 shares
CY2018 apyp Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
437235000 shares
CY2018 apyp Class Of Warrant Or Right With Reset Feature
ClassOfWarrantOrRightWithResetFeature
150681818 shares
CY2017 apyp Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2018 apyp Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2017 apyp Class Of Warrant Or Right Forfeited Or Cancellation
ClassOfWarrantOrRightForfeitedOrCancellation
0 shares
CY2018 apyp Class Of Warrant Or Right Forfeited Or Cancellation
ClassOfWarrantOrRightForfeitedOrCancellation
0 shares
CY2016Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.00
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.03
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0004
CY2017 apyp Class Of Warrant Or Right Weighted Average Exercise Price Granted
ClassOfWarrantOrRightWeightedAverageExercisePriceGranted
0.03
CY2018 apyp Class Of Warrant Or Right Weighted Average Exercise Price Granted
ClassOfWarrantOrRightWeightedAverageExercisePriceGranted
0.0002
CY2018 apyp Class Of Warrant Or Right Weighted Average Exercise Price With Reset Feature
ClassOfWarrantOrRightWeightedAverageExercisePriceWithResetFeature
0.0001
CY2017 apyp Class Of Warrant Or Right Weighted Average Exercise Price Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
0.00
CY2018 apyp Class Of Warrant Or Right Weighted Average Exercise Price Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
0.00
CY2018Q2 us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
20 day
CY2018Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0002
CY2017Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
85614 usd
CY2018Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
295541 usd
CY2017 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
31600 usd
CY2018 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
164657 usd
CY2017 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
241959 usd
CY2018 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
688234 usd
CY2017 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
55305786 shares
CY2018 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
585503747 shares
CY2017 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-85614 usd
CY2018 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-295541 usd
CY2017 apyp Number Of Lender
NumberOfLender
2 lender
CY2018 apyp Number Of Lender
NumberOfLender
2 lender
CY2018 us-gaap Debt Instrument Term
DebtInstrumentTerm
P6M
CY2018Q2 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
965401 usd
CY2018Q2 apyp Class Of Warrant Or Right Exercisable Of Common Stock Shares
ClassOfWarrantOrRightExercisableOfCommonStockShares
42500000 shares
CY2018 apyp Class Of Warrant Or Right Exercisable Price Per Share
ClassOfWarrantOrRightExercisablePricePerShare
0.00011
CY2018Q2 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
116666 usd
CY2018Q2 apyp Additional Class Of Warrant Or Right Number Of Securities Called By Warrants
AdditionalClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrants
394735000 shares
CY2018Q2 apyp Debt Instrument Interest Rate Default Percentage
DebtInstrumentInterestRateDefaultPercentage
24 usd
CY2018 apyp Term Of Warrant
TermOfWarrant
P5Y
CY2017Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
0 usd
CY2018Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
8333 usd
CY2017Q2 us-gaap Notes Payable
NotesPayable
0 usd
CY2018Q2 us-gaap Notes Payable
NotesPayable
8333 usd
CY2017Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0 usd
CY2018Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
644 usd
CY2017Q2 apyp Convertible Debt Related Party Current And Noncurrent
ConvertibleDebtRelatedPartyCurrentAndNoncurrent
0 usd
CY2018Q2 apyp Convertible Debt Related Party Current And Noncurrent
ConvertibleDebtRelatedPartyCurrentAndNoncurrent
8977 usd
CY2017Q2 apyp Convertible Debt Related Party Noncurrent
ConvertibleDebtRelatedPartyNoncurrent
0 usd
CY2018Q2 apyp Convertible Debt Related Party Noncurrent
ConvertibleDebtRelatedPartyNoncurrent
0 usd
CY2018 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.08 pure
CY2018 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.45 pure
CY2018Q2 apyp Value Assigned To Derivative Liability Recognized As Debt Discount
ValueAssignedToDerivativeLiabilityRecognizedAsDebtDiscount
8333 usd
CY2017 apyp Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
90000 usd
CY2018 apyp Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
285500 usd
CY2017 apyp Addition Of New Derivatives Recognized As Loss On Derivatives
AdditionOfNewDerivativesRecognizedAsLossOnDerivatives
241959 usd
CY2018 apyp Addition Of New Derivatives Recognized As Loss On Derivatives
AdditionOfNewDerivativesRecognizedAsLossOnDerivatives
689272 usd
CY2017 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
133481 usd
CY2018 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
223318 usd
CY2017Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
75000000 shares
CY2018 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
30000000 shares
CY2018 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
67500 usd
CY2017Q2 us-gaap Litigation Reserve
LitigationReserve
2426 usd
CY2018Q2 us-gaap Litigation Reserve
LitigationReserve
2484 usd
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200 usd
CY2018Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P3M
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60000 usd
CY2018 us-gaap Business Acquisition Description Of Acquired Entity
BusinessAcquisitionDescriptionOfAcquiredEntity
three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days' notice prior to expiration of an applicable term.
CY2018Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1500 shares
CY2018 us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
voting rights of 1,000 shares of common stock
CY2017 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
55305786 shares
CY2018 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
585503747 shares
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
31600 usd
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
164657 usd
CY2018 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
30000000 shares
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200 usd
CY2018 apyp Stock Issued Period For Common Stock Payable
StockIssuedPeriodForCommonStockPayable
57273 usd
CY2017Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
67500 usd
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
32000 usd
CY2017Q2 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
55000000 shares
CY2018Q2 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
25000000 shares
CY2017Q2 apyp Stock Payable To Consulting Services Common Shares Value
StockPayableToConsultingServicesCommonSharesValue
105000 usd
CY2018Q2 apyp Stock Payable To Consulting Services Common Shares Value
StockPayableToConsultingServicesCommonSharesValue
47727 usd
CY2017 apyp Stock Payable For Service
StockPayableForService
105000 usd
CY2017 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
160587 usd
CY2018 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
219755 usd
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-160587 usd
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-219755 usd
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
336934 usd
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
556689 usd
CY2017Q2 apyp Income Tax Reconciliation Income Tax Expense Benefit Defferd Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitDefferdStatutoryIncomeTaxRate
0 usd
CY2018Q2 apyp Income Tax Reconciliation Income Tax Expense Benefit Defferd Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitDefferdStatutoryIncomeTaxRate
-222676 usd
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
336934 usd
CY2018Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
334013 usd
CY2017Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2018Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2018Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1590540 usd
CY2017 apyp Stock Issued During Period Value Common Stock Issued For Conversion Of Debt And Resolution Of Derivative Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfDebtAndResolutionOfDerivativeLiabilities
117214 usd
CY2018 apyp Stock Issued During Period Value Common Stock Issued For Conversion Of Debt And Resolution Of Derivative Liabilities
StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfDebtAndResolutionOfDerivativeLiabilities
401648 usd
CY2018 apyp Stock Issued During Period Issued For Settlement Agreement
StockIssuedDuringPeriodIssuedForSettlementAgreement
67500 usd
CY2018 apyp Common Stock Issued Exchanged For Common Stock Payable
CommonStockIssuedExchangedForCommonStockPayable
200 usd
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2900 usd
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2018 dei Entity Shell Company
EntityShellCompany
false

Files In Submission

Name View Source Status
0001640334-18-001936-index-headers.html Edgar Link pending
0001640334-18-001936-index.html Edgar Link pending
0001640334-18-001936.txt Edgar Link pending
0001640334-18-001936-xbrl.zip Edgar Link pending
apyp-20180630.xsd Edgar Link pending
apyp_10k.htm Edgar Link pending
apyp_ex211.htm Edgar Link pending
apyp_ex311.htm Edgar Link pending
apyp_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
apyp-20180630_lab.xml Edgar Link unprocessable
apyp-20180630_pre.xml Edgar Link unprocessable
apyp-20180630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apyp-20180630.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
apyp-20180630_cal.xml Edgar Link unprocessable